White Papers / Tech Papers

5 ADC Manufacturing Challenges You Need To Know

Below are five key areas where pharmaceutical manufacturers may face the biggest uphill battles.

Company Logo

Released By Ajinomoto Bio-Pharma Services

The unique targeting capabilities and promising clinical trial results of antibody- drug conjugates (ADCs) have made them an exciting and promising treatment in the fight against cancer. According to recent analysis, experts anticipate the ADC market to be worth $10 billion annually by 2025. However, despite this tremendous growth, drugmakers still face a number of challenges in the manufacturing process for ADCs. Below are five key areas where pharmaceutical manufacturers may face the biggest uphill battles.

DOWNLOAD TO LEARN MORE>>>>

Download White Papers / Tech Papers Now

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters